What are analysts forecasting for SRPT's Q1 2025 earnings?

Analysts are forecasting that Sarepta Therapeutics (SRPT) will report earnings per share (EPS) of approximately $1.68 for the fiscal quarter ending March 31, 2025, according to the latest estimates. The estimated revenue for the same period is $656.77 million.